PEPE, MARTINO
 Distribuzione geografica
Continente #
NA - Nord America 1.456
EU - Europa 562
AS - Asia 215
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 2.237
Nazione #
US - Stati Uniti d'America 1.448
IT - Italia 176
CN - Cina 110
FR - Francia 99
SE - Svezia 97
SG - Singapore 79
DE - Germania 63
GB - Regno Unito 35
FI - Finlandia 30
IN - India 13
BE - Belgio 11
AT - Austria 10
RU - Federazione Russa 10
CZ - Repubblica Ceca 8
NL - Olanda 8
VN - Vietnam 8
CA - Canada 7
UA - Ucraina 5
BG - Bulgaria 2
CH - Svizzera 2
CO - Colombia 2
ES - Italia 2
PK - Pakistan 2
AU - Australia 1
HK - Hong Kong 1
KH - Cambogia 1
KR - Corea 1
LT - Lituania 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
Totale 2.237
Città #
Fairfield 233
Chandler 144
Woodbridge 125
Ashburn 117
Houston 97
Seattle 83
Cambridge 78
Nyköping 72
New York 62
Wilmington 60
Singapore 52
Ann Arbor 48
Bari 45
Marseille 36
Beijing 31
Munich 24
Helsinki 21
Lawrence 21
Roxbury 20
Nanjing 16
Jacksonville 14
Brussels 11
Des Moines 11
San Diego 10
Brooklyn 9
Dong Ket 8
Foggia 8
Inglewood 8
Santa Clara 8
Bisceglie 7
Dearborn 7
Los Angeles 7
Princeton 7
Shenyang 7
Brno 6
London 6
Pune 6
Barletta 5
Paris 5
Shenzhen 5
Jiaxing 4
Naples 4
Romola 4
Toronto 4
Chicago 3
Frankfurt am Main 3
Guangzhou 3
Hebei 3
State College 3
Stimigliano 3
Triggiano 3
Wuxi 3
A Coruña 2
Angeren 2
Assago 2
Atrani 2
Bengaluru 2
Boardman 2
Bogotá 2
Changsha 2
Espoo 2
Florence 2
Grottaglie 2
Lamezia Terme 2
Manfredonia 2
Mesagne 2
Nanchang 2
Okara 2
Prague 2
Quanzhou 2
Raipur 2
Secaucus 2
Sittard 2
Stockholm 2
Taranto 2
Vienna 2
Washington 2
Zhengzhou 2
Adelfia 1
Altamura 1
Apricena 1
Baar 1
Baotou 1
Bitonto 1
Buffalo 1
Catania 1
Chiswick 1
Clearwater 1
Cleveland 1
Craco 1
Edinburgh 1
Fiorano Modenese 1
Forest City 1
Fuzhou 1
Geneva 1
Grefrath 1
Harbin 1
Hounslow 1
Imperia 1
Jinhua 1
Totale 1.654
Nome #
A Striking Coronary Artery Pattern in a Grown-Up Congenital Heart Disease Patient 136
Time-dependent benefits of pre-treatment with new oral P2Y12 -inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction 124
Functional study of a KCNH2 mutant: Novel insights on the pathogenesis of the LQT2 syndrome 124
How to Approach a Spontaneous Coronary Artery Dissection: An Up-To-Date 118
STEMI and NSTEMI ACS in a 30-Year-Old Patient: An Extremely Rare Complication of a Left Atrial Myxoma. 110
'Broken-heart' syndrome: ventricular septal perforation in a takotsubo cardiomyopathy 109
Life-threatening acute myocardial infarction due to left main dissection during radiofrequency transcatheter ablation of atrial tachycardia 107
Massive stent thrombosis during active ulcerative colitis: the tricky balance between manifest hemorrhagic and concealed thrombotic risk 99
null 96
Correlation between endothelial dysfunction and myocardial damage in acute phase of Tako-Tsubo cardiomyopathy: brachial flow mediated dilation as a potential marker for assessment of patient with Tako-Tsubo. 95
Role of plasma glucose level on myocardial perfusion in ST-segment elevation myocardial infarction patients 92
null 88
null 77
null 77
null 74
null 70
Cardiogenic Shock following Acute Myocardial Infarction: What's New? 57
Infiammazione Th17 dipendente e attivazione metallo-proteasica dopo angioplastica coronarica. 50
Pro-inflammatory cytokines as emerging molecular determinants in cardiolaminopathies 41
Comparison of Outcomes of Transcatheter Aortic Valve Implantation in Patients ≥85 Years Versus Those <85 Years 40
Importance of clinical suspicion and multidisciplinary management for early diagnosis of a cardiac laminopathy patient: A case report 40
Percutaneous Edge-to-Edge Transcatheter Mitral Valve Repair: Current Indications and Future Perspectives. 33
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study 26
Comparative Effectiveness and Safety of Polymer-Free Biolimus-Eluting Stent and Durable Polymer Everolimus-Eluting Stent in All-Comer Patients Who Underwent Percutaneous Coronary Interventions 24
Percutaneous exclusion of ascending aorta pseudoaneurysms: still an interventional challenge? 23
Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease: A Propensity Score-Adjusted Analysis From the RISPEVA Registry 21
Fractional flow reserve and intravascular scan as part of the coronary fistulas diagnostic process: Future perspectives 20
Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis? 19
Inflammatory bowel disease and acute coronary syndromes: From pathogenesis to the fine line between bleeding and ischemic risk. 19
Corrigendum to "A Striking Coronary Artery Pattern in a Grown-Up Congenital Heart Disease Patient" 19
Baseline, procedural and outcome features of patients undergoing transcatheter aortic valve implantation according to different body mass index categories 19
Assessing the Best Prognostic Score for Transcatheter Aortic Valve Implantation (from the RISPEVA Registry) 18
A Young Patient Presenting with Dilated Cardiomyopathy and Renal Infarction during Treatment with Isotretinoin: Mere Coincidence or Serious Side Effect of a Drug Commonly Used in Adolescence? 18
Targeting unfolded protein response reverts ER stress and ER Ca2+ homeostasis in cardiomyocytes expressing the pathogenic variant of Lamin A/C R321X 17
Prognostic value of 12-leads admission electrocardiogram in low-risk patients hospitalized for COVID-19 16
Degenerative Severe Aortic Stenosis and Concomitant Coronary Artery Disease: What Is Changing in the Era of the "Transcatheter Revolution"? 16
Remote ischemic preconditioning in isolated valve intervention. A pooled meta-analysis 16
A concealed case of takotsubo syndrome as consequence of ab ingestis episode in a revascularized patient 13
Comparative Effectiveness and Safety of Polymer-Free Biolimus-Eluting Stent and Durable Polymer Everolimus-Eluting Stent in All-Comer Patients Undergoing Percutaneous Coronary Interventions 13
Anti-Inflammatory Therapy for Acute Coronary Syndromes: Is It Time for a Shift in the Treatment Paradigm? 12
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study 12
Role of pre-operative embolization in carotid body tumor surgery according to Shamblin classification: A systematic review and meta-analysis 11
Long-Term Follow-Up of Transcatheter Aortic Valve Implantation With Portico Versus Evolut Devices 11
MitraClip™ implantation plus left atrial appendage occlusion in a hereditary hemorrhagic telangiectasia patient 11
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation 10
Antithrombotic Therapy for Vascular Disease and Intervention: The Best Is Yet to Come? 10
Uric Acid Induces a Proatherothrombotic Phenotype in Human Endothelial Cells by Imbalancing the Tissue Factor/Tissue Factor Pathway Inhibitor Pathway 10
Role of Nuclear Lamin A/C in the Regulation of Nav1.5 Channel and Microtubules: Lesson From the Pathogenic Lamin A/C Variant Q517X 10
Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes 9
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart 9
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry 9
Transcatheter aortic valve implantation with Allegra: procedural and mid-term outcomes according to experience phase in a high-volume center 9
Missense and Non-Missense Lamin A/C Gene Mutations Are Similarly Associated with Major Arrhythmic Cardiac Events: A 20-Year Single-Centre Experience 9
Clinical use of cangrelor: a real-world multicenter experience from South Italy 9
Thrombocytopenia Complicating Transcatheter Aortic Valve Implantation: Differences Between Two New-Generation Devices 9
Impact of Tirofiban on Serum Troponin Changes in Patients Undergoing Carotid Artery Stenting: A Propensity Matched Analysis 8
Aortic valve fibroelastoma presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA): a case report and review of the literature 8
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19 8
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19]) 8
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry 8
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry 7
Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis 7
Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction 7
Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry 6
Th2-dependent cytokine release in patients treated with coronary angioplasty 6
Emergency coronary and peripheral arteries combined with percutaneous intervention in the elderly: success or therapeutic excess? 6
Giant Cardiac Fibroma in a Completely Asymptomatic Teenager 6
Transcatheter aortic valve implantation in patients with age ≤70 years: experience from two leading structural heart disease centers 6
Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score 6
Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19 6
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry 6
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis 5
No Reflow-phenomenon: from Current State of the Art to Future Perspectives 5
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry 5
Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry) 5
Direct and indirect effects of COVID-19 on acute coronary syndromes: Can we pick the worst? 5
TAVI-CT score to evaluate the anatomic risk in patients undergoing transcatheter aortic valve implantation 4
Alex Plus Versus Xience Drug-Eluting Stents for Percutaneous Coronary Intervention in Routine Clinical Practice: A Propensity Score-Matched Analysis 4
Comparing the Safety and Effectiveness of Five Leading New-Generation Devices for Transcatheter Aortic Valve Implantation: Twelve-Month Results From the RISPEVA Study 4
Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases 4
COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany). 4
The Novel FlexNav Delivery System for Transcatheter Aortic Valve Implantation With the Portico Device: A Case Series 4
Aortic coarctation: guidelines mismatch across the ocean 4
Underlying heart diseases and acute COVID-19 outcomes 4
Minimally invasive approaches to primary cardiac tumors: A systematic review and meta-analysis 3
Comparative one-month safety and effectiveness of five leading new-generation devices for transcatheter aortic valve implantation 3
The best way to transcatheter aortic valve implantation: from standard to new approaches 3
Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy 3
Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections 3
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2) 2
Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study 2
Prime time for the sweet spot in timing of coronary invasive approach in patients with non-ST elevation myocardial infarction 2
Omega-3 fatty acids for the prevention of myocardial infarction and arrhythmias 2
Unsupervised Machine Learning with Cluster Analysis in Patients Discharged after an Acute Coronary Syndrome: Insights from a 23,270-Patient Study 2
Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure 2
Comparison of ProGlide vs. Prostar in patients undergoing transcatheter aortic valve implantation 1
Sudden cardiac death secondary to demonstrated reperfusion ventricular fibrillation in a woman with Takotsubo cardiomyopathy 1
Reverse takotsubo cardiomyopathy followed by left ventricle outflow tract obstruction: A dangerous relay race 1
A novel multidisciplinary approach in an LMNA-mutated patient: the importance of considering the overall clinical picture for the early diagnosis 1
RETRACTED: Identification of a coronary vascular progenitor cell in the human heart 1
Totale 2.532
Categoria #
all - tutte 14.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.436


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020406 0 0 0 0 82 40 46 54 65 55 42 22
2020/2021283 9 29 11 24 39 11 11 42 26 42 13 26
2021/2022197 22 4 2 4 10 27 16 12 14 19 26 41
2022/2023508 35 51 23 24 33 50 3 59 92 76 43 19
2023/2024338 22 55 23 27 36 84 9 13 10 12 13 34
2024/2025369 95 22 83 136 33 0 0 0 0 0 0 0
Totale 2.534